EDWARDS LIFESCIENCES CORP (EW)
US28176E1082 - Common Stock
EDWARDS LIFESCIENCES CORP
NYSE:EW (11/21/2024, 12:58:01 PM)
70.61
+1.07 (+1.54%)
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 19,800 full-time employees. The company went IPO on 2000-03-27. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. The company also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. The company conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. The company sells products that are used to treat advanced cardiovascular disease in all regions.
Company Info
EDWARDS LIFESCIENCES CORP
One Edwards Way
Irvine CALIFORNIA 92614
P: 19492502500
CEO: Michael A. Mussallem
Employees: 19800
Website: https://www.edwards.com
EW News
an hour ago - Faruqi & Faruqi, LLPSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation...
7 hours ago - The Gross Law FirmShareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact The Gross Law Firm to Learn More/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased...
a day ago - Robbins Geller Rudman & Dowd LLPEW INVESTOR NOTICE: Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edwards Lifesciences Corporation (NYSE: EW)...
2 days ago - Bragar Eagel & SquireEDWARDS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm2 days ago - Bernstein Liebhard LLPEDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Bernstein Liebhard LLP Reminds Edwards Lifesciences Corporation Investors of Upcoming Deadline2 days ago - Levi & Korsinsky, LLPLevi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action...
EW Twits
Here you can normally see the latest stock twits on EW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
